MassMutual Private Wealth & Trust’s Roivant Sciences ROIV Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$37.2K	Sell	1,016 -50	-5%	-$1.81K	﹤0.01%	832
2026 Q2	$37.7K	Buy	1,066 +162	+18%	+$4.79K	﹤0.01%	882
2026 Q1	$25K	Buy	904 +100	+12%	+$2.57K	﹤0.01%	1010
2025 Q4	$17.4K	Buy	804 +159	+25%	+$3.14K	﹤0.01%	1171
2025 Q3	$9.8K	Sell	645 -36	-5%	-$446	﹤0.01%	1409
2025 Q2	$7.68K	Buy	681 +276	+68%	+$2.99K	﹤0.01%	1467
2025 Q1	$4.09K	Buy	405 +196	+94%	+$2.12K	﹤0.01%	1677
2024 Q4	$2.47K	Buy	+209	New	+$2.47K	﹤0.01%	1765

Other funds holding ROIV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return

MassMutual Private Wealth & Trust's ROIV Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Roivant Sciences (ROIV) stake by 4.7% in Q3 2026, selling an estimated $1.81K and leaving 1,016 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #832.

MassMutual Private Wealth & Trust first reported a position in ROIV in Q4 2024 and has held it in 8 quarters since. The position peaked at $37.7K in Q2 2026. 234 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

MassMutual Private Wealth & Trust held 1,016 shares of Roivant Sciences worth $37.2K as of Q3 2026.
MassMutual Private Wealth & Trust sold 50 Roivant Sciences shares in Q3 2026, an estimated $1.81K.
Roivant Sciences made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #832 holding.
MassMutual Private Wealth & Trust first reported a position in Roivant Sciences in Q4 2024 and has held it in 8 quarters since.
MassMutual Private Wealth & Trust's Roivant Sciences position peaked at $37.7K in Q2 2026.
234 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.